LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Selumetinib | 10.0 | uM | LJP6 | 72 | hr | 962 | 1692 | 10605 | 0.1596 | 0.0758 |
MCF 10A | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 962 | 9031 | 10605 | 0.8516 | 0.8368 |
MCF 10A | Sorafenib | 10.0 | uM | LJP6 | 72 | hr | 962 | 4414 | 10605 | 0.4163 | 0.3580 |
MCF 10A | SU11274 | 10.0 | uM | LJP5 | 72 | hr | 962 | 3529 | 10605 | 0.3328 | 0.2662 |
MCF 10A | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 962 | 1123 | 10605 | 0.1059 | 0.0167 |
MCF 10A | TGX221 | 10.0 | uM | LJP5 | 72 | hr | 962 | 10603 | 10605 | 0.9998 | 0.9998 |
MCF 10A | Torin1 | 10.0 | uM | LJP6 | 72 | hr | 962 | 1262 | 10605 | 0.1190 | 0.0311 |
MCF 10A | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 962 | 1277 | 10605 | 0.1204 | 0.0327 |
MCF 10A | Tozasertib | 10.0 | uM | LJP5 | 72 | hr | 962 | 1266 | 10605 | 0.1194 | 0.0316 |
MCF 10A | Trametinib | 10.0 | uM | LJP5 | 72 | hr | 962 | 1979 | 10605 | 0.1866 | 0.1055 |
MCF 10A | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 962 | 1247 | 10605 | 0.1176 | 0.0296 |
MCF 10A | Vemurafenib | 10.0 | uM | LJP5 | 72 | hr | 962 | 4165 | 10605 | 0.3928 | 0.3322 |
MCF 10A | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 962 | 594 | 10605 | 0.0561 | -0.0381 |
MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 962 | 574 | 10605 | 0.0541 | -0.0403 |
MCF 10A | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 962 | 1427 | 10605 | 0.1346 | 0.0482 |
MCF 10A | WZ3105 | 10.0 | uM | LJP5 | 72 | hr | 962 | 185 | 10605 | 0.0175 | -0.0806 |
MCF 10A | XMD11-50 | 10.0 | uM | LJP6 | 72 | hr | 962 | 1194 | 10605 | 0.1127 | 0.0241 |
MCF 10A | Y39983 | 10.0 | uM | LJP6 | 72 | hr | 962 | 4273 | 10605 | 0.4030 | 0.3434 |
MCF 10A | YM 201636 | 10.0 | uM | LJP5 | 72 | hr | 962 | 2670 | 10605 | 0.2518 | 0.1771 |
MCF 10A | ZSTK474 | 10.0 | uM | LJP6 | 72 | hr | 962 | 1349 | 10605 | 0.1273 | 0.0402 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3665 | 4093 | 0.8955 | 0.8517 |
MCF7 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3392 | 4093 | 0.8287 | 0.7569 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 673 | 4093 | 0.1646 | -0.1859 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1716 | 4093 | 0.4193 | 0.1756 |
MCF7 | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2897 | 4093 | 0.7079 | 0.5853 |